Routine use of recombinant erythropoietin in patients of chronic kidney disease obtes the chances of
Correct Answer: Regular blood transfusions
Description: Answer- A. Regular blood transfusionsRecombinant human EPO and modified EPO products, such as darbepoetin- alpha, has been one of the most significant advances in the care of renal patients since the introduction of dialysis and renal transplantation.The routine use of these products has obted the need for regular blood transfusions in severely anemic CKD patients.Frequent blood transfusions in dialysis patients also leads to the development of allo-antibodies that could sensitize the patient to donor kidney antigens and make renal transplantation difficult.Adequate bone marrow iron stores should be available before treatment with EPO is initiated.For patients on hemodialysis, IV iron can be administered during dialysis.
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now